News & Media


December 22, 2023

Three perspectives on the challenges and trends in gene therapy

In this blog, three experts in the field of gene therapy from Andelyn Biosciences give their perspectives on challenges and...


February 18, 2023

Suspension Cell Culture in Cell and Gene Therapy

The Growing Demand for Suspension Cell Culture Platforms The biopharmaceutical sector is growing and demand for viral vectors as tools...


February 18, 2023

Genetic Engineering

Delivering Genetic Editing Therapies to Market In the past 10 years, our understanding of molecular biology and genetic engineering has...


November 28, 2022

Trends in AAV development and manufacturing for gene therapies

Following pre-clinical and clinical success, adeno-associated viral vectors (AAVs), have become a leading tool for gene delivery in the treatment...


February 28, 2022

Andelyn Biosciences Observes Rare Disease Day

Observed every year on the last day in February, Rare Disease Day works to raise awareness for rare diseases and...


February 11, 2022

Andelyn’s Women in Science

Every day here at Andelyn Biosciences is Women in Science Day! We are proud that 50% of our scientists on...


February 8, 2022

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Gene therapies offer an unprecedented ability to treat — and even cure — genetic diseases, and their potential spanning diverse...


November 11, 2021

Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing

Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...


October 22, 2021

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...


September 23, 2021

Navigating Analytical Requirements for GMP Viral Vectors

The analytical requirements for viral vectors used to deliver gene therapies are complex and constantly evolving. The keys to success,...

Connect Here With Our Business Team